Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations

被引:6
|
作者
Yang, Rui [1 ]
Wu, Sijin [1 ]
Wang, Shen [1 ]
Rubino, Grace [2 ]
Nickels, Jonathan D. [3 ]
Cheng, Xiaolin [1 ,4 ]
机构
[1] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Engn, Dept Chem & Biomol Engn, Columbus, OH USA
[3] Univ Cincinnati, Dept Chem & Environm Engn, Cincinnati, OH 45221 USA
[4] Ohio State Univ, Translat Data Analyt Inst TDAI, Columbus, OH 43210 USA
关键词
COVID-19; coronavirus; envelope (E) protein; SARS-CoV-2; E protein inhibitors; RESPIRATORY SYNDROME CORONAVIRUS; PARAMETERS; SOFTWARE; STRATEGY; EWALD; IONS; GUI;
D O I
10.3389/fmolb.2022.1027223
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
COVID-19 has become an unprecedented threat to human health. The SARS-CoV-2 envelope (E) protein plays a critical role in the viral maturation process and pathogenesis. Despite intensive investigation, its structure in physiological conditions remains mysterious: no high-resolution full-length structure is available and only an NMR structure of the transmembrane (TM) region has been determined. Here, we present a refined E protein structure, using molecular dynamics (MD) simulations to investigate its structure and dynamics in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer system. Our initial homology model based upon the SARS-CoV E protein structure is shown to be unstable in the lipid bilayer, and the H3 helices tend to move away from the membrane center to the membrane-water interface. A more stable model was developed by replacing all H3 helices with the fully equilibrated H3 structure sampled in the MD simulations. This refined model exhibited more favorable contacts with lipids and water than the original homology model and induced local membrane curvature, decreasing local lipid order. Interestingly, the pore radius profiles showed that the channel in both homology and refined models remained in a closed state throughout the simulations. We also demonstrated the utility of this structure to develop anti-SARS-CoV-2 drugs by docking a library of FDA-approved, investigational, and experimental drugs to the refined E protein structure, identifying 20 potential channel blockers. This highlights the power of MD simulations to refine low-resolution structures of membrane proteins in a native-like membrane environment, shedding light on the structural features of the E protein and providing a platform for the development of novel antiviral treatments.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Evolution of Stronger SARS-CoV-2 Variants as Revealed Through the Lens of Molecular Dynamics Simulations
    Alec J. Wozney
    Macey A. Smith
    Mobeen Abdrabbo
    Cole M. Birch
    Kelsey A. Cicigoi
    Connor C. Dolan
    Audrey E. L. Gerzema
    Abby Hansen
    Ethan J. Henseler
    Ben LaBerge
    Caterra M. Leavens
    Christine N. Le
    Allison C. Lindquist
    Rikaela K. Ludwig
    Maggie G. O’Reilly
    Jacob H. Reynolds
    Brandon A. Sherman
    Hunter W. Sillman
    Michael A. Smith
    Marissa J. Snortheim
    Levi M. Svaren
    Emily C. Vanderpas
    Aidan Voon
    Miles J. Wackett
    Moriah M. Weiss
    Sanchita Hati
    Sudeep Bhattacharyya
    The Protein Journal, 2022, 41 : 444 - 456
  • [42] Molecular characterization of SARS-CoV-2 nucleocapsid protein
    Huang, Yanping
    Chen, Junkai
    Chen, Siwei
    Huang, Congcong
    Li, Bei
    Li, Jian
    Jin, Zhixiong
    Zhang, Qiwei
    Pan, Pan
    Du, Weixing
    Liu, Long
    Liu, Zhixin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [43] Applications of Protein Secondary Structure Algorithms in SARS-CoV-2 Research
    Kruglikov, Alibek
    Rakesh, Mohan
    Wei, Yulong
    Xia, Xuhua
    JOURNAL OF PROTEOME RESEARCH, 2021, 20 (03) : 1457 - 1463
  • [44] Structure of SARS-CoV-2 membrane protein essential for virus assembly
    Zhang, Zhikuan
    Nomura, Norimichi
    Muramoto, Yukiko
    Ekimoto, Toru
    Uemura, Tomoko
    Liu, Kehong
    Yui, Moeko
    Kono, Nozomu
    Aoki, Junken
    Ikeguchi, Mitsunori
    Noda, Takeshi
    Iwata, So
    Ohto, Umeharu
    Shimizu, Toshiyuki
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [45] Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study
    Dehury, Budheswar
    Raina, Vishakha
    Misra, Namrata
    Suar, Mrutyunjay
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (18) : 7231 - 7245
  • [46] SARS-CoV-2 Papain-Like Protease: Structure, Function and Inhibition
    Ullrich, Sven
    Nitsche, Christoph
    CHEMBIOCHEM, 2022, 23 (19)
  • [47] Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity
    Park, Sang Ho
    Siddiqi, Haley
    Castro, Daniela V.
    De Angelis, Anna A.
    Oom, Aaron L.
    Stoneham, Charlotte A.
    Lewinski, Mary K.
    Clark, Alex E.
    Croker, Ben A.
    Carlin, Aaron F.
    Guatelli, John
    Opella, Stanley J.
    PLOS PATHOGENS, 2021, 17 (05)
  • [48] Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations
    Zhang, Chuanming
    Zhang, Chao
    Meng, Yanli
    Li, Tai
    Jin, Zhe
    Hou, Shicheng
    Hu, Chun
    MENDELEEV COMMUNICATIONS, 2022, 32 (03) : 334 - 335
  • [49] SARS-CoV-2 envelope protein triggers depression-like behaviors and dysosmia via TLR2-mediated neuroinflammation in mice
    Su, Wenliang
    Ju, Jiahang
    Gu, Minghui
    Wang, Xinrui
    Liu, Shaozhuang
    Yu, Jiawen
    Mu, Dongliang
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [50] Plant-based expression and characterization of SARS-CoV-2 virus-like particles presenting a native spike protein
    Jung, Jae-Wan
    Zahmanova, Gergana
    Minkov, Ivan
    Lomonossoff, George P.
    PLANT BIOTECHNOLOGY JOURNAL, 2022, 20 (07) : 1363 - 1372